Clinical Trial Update: Oxaliplatin in Rectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial of oxaliplatin in rectal cancer sponsored by Sanofi has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Rectal Neoplasms | Phase 1, Phase 2 | Status: TERMINATED